Adriana Campa to Adult
This is a "connection" page, showing publications Adriana Campa has written about Adult.
Connection Strength
0.186
-
Contreras-P?rez ME, Diaz-Martinez J, Langwerden RJ, Hospital MM, Morris SL, Wagner EF, Campa AL. Preliminary Analysis of COVID-19 Vaccination Factors among Native and Foreign-Born Hispanic/Latine Adults Residing in South Florida, U.S.A. Int J Environ Res Public Health. 2022 10 14; 19(20).
Score: 0.062
-
Baum MK, Tamargo JA, Ehman RL, Sherman KE, Chen J, Liu Q, Mandler RN, Teeman C, Martinez SS, Campa A. Heroin use is associated with liver fibrosis in the Miami Adult Studies on HIV (MASH) cohort. Drug Alcohol Depend. 2021 03 01; 220:108531.
Score: 0.055
-
Burke SL, Grudzien A, Li T, Garcia S, Martinez SS, Jurich E, Jimenez DR, Hern?ndez J, Liu Q, Tyrell TA, Goulett N, Campa AL, Bursac Z, Baum MK. The influence of socioeconomic factors and apolipoprotein e genotype on cognitive outcomes in a multi-ethnic sample living with HCV and HIV. Int J STD AIDS. 2025 Aug; 36(9):719-730.
Score: 0.019
-
Burke SL, Grudzien A, Li T, Garcia S, Martinez SS, Jurich E, Jimenez DR, Hern?ndez J, Liu Q, Tyrell TA, Campa AL, Johnson A, Bursac Z, Baum MK. Substance use moderates relationships between apolipoprotein E genotype, hepatitis C, cognition, and depression in Miami Adult Studies on HIV (MASH) participants. J Neurovirol. 2024 12; 30(5-6):500-512.
Score: 0.018
-
Wagner EF, Langwerden RJ, Morris SL, Ward MK, Trepka MJ, Campa AL, Howard MM, Charles SC, Garba NA, Hospital MM. Virtual town halls addressing vaccine hesitancy among racial/ethnic minorities: Preliminary findings. J Am Pharm Assoc (2003). 2022 Jan-Feb; 62(1):317-325.
Score: 0.014
-
Tamargo JA, Campa A, Martinez SS, Li T, Sherman KE, Zarini G, Meade CS, Mandler RN, Baum MK. Cognitive Impairment among People Who Use Heroin and Fentanyl: Findings from the Miami Adult Studies on HIV (MASH) Cohort. J Psychoactive Drugs. 2021 Jul-Aug; 53(3):215-223.
Score: 0.014
-
Kaiser JD, Campa AM, Ondercin JP, Leoung GS, Pless RF, Baum MK. Micronutrient supplementation increases CD4 count in HIV-infected individuals on highly active antiretroviral therapy: a prospective, double-blinded, placebo-controlled trial. J Acquir Immune Defic Syndr. 2006 Aug 15; 42(5):523-8.
Score: 0.005